Creating Links

Our achievements leave their mark in the society

JAIME FECED, NEW CEO TO LEAD THE CONSOLIDATION OF ADL BIONATUR INDUSTRIAL BUSINESS MODEL

Leer

ADL Bionatur Solutions wins new fermentation client with contract revenues of 20 Million Euros

Leer

ADL BIONATUR SOLUTIONS REPORTS CONTINUED STRONG REVENUE GROWTH FOR THIRD QUARTER

Leer

ADL BIONATUR SOLUTIONS INCREASES REVENUES BY 138% AND CONFIRMS POSITIVE OPERATING RESULTS

Leer

ADL BIONATUR SOLUTIONS REINFORCES ITS GROWTH STRATEGY WITH A EUR 25 MILLION DEBT FINANCING FROM KARTESIA

Leer

ADL BIONATUR SOLUTIONS ENTERS INTO AN INITIAL EUR 13 MILLION STRATEGIC ALLIANCE WITH JAPANESE PHARMA COMPANY

Leer

ADL Bionatur Solutions and Amyris Expand Contract to 2020

Leer

ADL BIONATUR SOLUTIONS INCREASES 2019 PRODUCTION FOR A GLOBAL NUTRITION COMPANY FOR ADDITIONAL REVENUES OF OVER EUR 2.5 MILLION

Leer

ADL BIONATUR SOLUTIONS REPORTS STRONG FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2019

Leer

BANCO SABADELL GIVES ADL BIONATUR SOLUTIONS AN UPSIDE POTENTIAL OF 78%

Leer

Nutricion Center NC and ADL Bionatur Solutions sign a strategic alliance to tackle weight control by rebalancing the gut microbiome

Leer

ANALYST COVERAGE OF ADL BIONATUR SOLUTIONS INITIATED BY CHECKPOINT WITH A TARGET PRICE OF EUR 3.20 PER SHARE

Leer

EDISON INITIATES COVERAGE OF ADL BIONATUR SOLUTIONS FORECASTING AN EQUITY VALUATION OF EUR 2.37 PER SHARE WITH AN UPSIDE POTENTIAL OF 42%

Leer

AMYRIS AND ADL BIONATUR SOLUTIONS EXPAND PRODUCTION AGREEMENT TO MEET GROWING DEMAND

Leer

Fermentalg and ADL BioPharma announce a major manufacturing alliance to produce Omega 3 food supplements

Leer

ADL Bionatur Solutions Raises € 12 million with Institutional Investors

Leer

Amyris Expands Production Contract with ADL BioPharma Due to Demand Growth

Leer

ADL Bionatur Solutions Signs Contract Extension of up to EUR 6.2 Million

Leer

ADL Bionatur Solutions Board of Directors aims for capital increase of up to €15 million

Leer

Future strategy for the new entity ADL Bionatur Solutions

Leer

BIONATURIS SHAREHOLDERS APPROVES MERGER WITH ADL BIOPHARMA TO CREATE EUROPE’S NEW BIOTECH SOLUTION LEADER

Leer